NEET counselling: Maha CET Cell notifies revised round 3 schedule, check new dates, guidelines for candidates
Maharashtra:The Maharashtra State Common Entrance Test Cell (Maha CET Cell) has started theNEET UGRound 3 counselling for the academic year 2025 after the delay caused by to detection of forged documents and the addition of new MBBS seats approved by the National Medical Commission (NMC). Candidates who did not report or surrender their seats in CAP Round 2 can opt for this round. The link to register and update the counselling schedule for MBBS and BDS admissions is now active on the official portal of Maha CET Cell. The Maharashtra CET Cell has again revised the CAP Round 3 schedule based on the updates received from the Medical Counselling Committee (MCC), New Delhi. The updated combined merit list was published on 27 October 2025. After this, the Online editing/filling of preferences will take place from 27–28 October 2025, till 11:59 PM. The CAP Round 3 selection list will be declared on 30 October 2025 and joining with original documents and payment of the fee will be done from 31 October – 4 November 2025, till 5:30 PM. 1. Candidates who have already registered need not register again.
Disclaimer: This website is designed for healthcare professionals and serves solely for informational purposes.
The content provided should not be interpreted as medical advice, diagnosis, treatment recommendations, prescriptions, or endorsements of specific medical practices. It is not a replacement for professional medical consultation or the expertise of a licensed healthcare provider.
Given the ever-evolving nature of medical science, we strive to keep our information accurate and up to date. However, we do not guarantee the completeness or accuracy of the content.
If you come across any inconsistencies, please reach out to us at
admin@doctornewsdaily.com.
We do not support or endorse medical opinions, treatments, or recommendations that contradict the advice of qualified healthcare professionals.
By using this website, you agree to our
Terms of Use,
Privacy Policy, and
Advertisement Policy.
For further details, please review our
Full Disclaimer.
0 Comments
Post a comment
No comments yet. Be the first to comment!